Results 21 to 30 of about 1,757,150 (280)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
BACKGROUND Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial.
S. Mulangu +50 more
semanticscholar +1 more source
The laboratory health system and its response to the Ebola virus disease outbreak in Liberia
The laboratory system in Liberia has generally been fragmented and uncoordinatedAccordingly, the country’s Ministry of Health established the National Reference Laboratoryto strengthen and sustain laboratory services. However, diagnostic testing services
Stephen B. Kennedy +7 more
doaj +1 more source
Introduction: This article describes a retrospective review of participant follow-up and retention strategies in the Partnership for Research on the Ebola Virus in Liberia (PREVAIL) I Vaccine Trial.
Sarah Browne +6 more
doaj +1 more source
During outbreaks of virus diseases, many variants may appear, some of which may be of concern. Stability in an aerosol of several Ebola virus and Marburg virus variants was investigated.
Sophie J. Smither +2 more
doaj +1 more source
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
The most recent Ebola virus outbreak in West Africa, which was unprecedented in the number of cases and fatalities, geographic distribution, and number of nations affected, highlights the need for safe, effective, and readily available antiviral agents ...
Travis K Warren +61 more
semanticscholar +1 more source
Pre-Ebola virus disease laboratory system and related challenges in Liberia
Prior to the Ebola virus disease outbreak in Liberia, the laboratory system was duplicativefragmented and minimally coordinated. The National Reference Laboratory was conceptualisedto address the existing challenges by promoting the implementation of ...
Stephen B. Kennedy +7 more
doaj +1 more source
Exploiting the Reverse Vaccinology Approach to Design Novel Subunit Vaccine against Ebola Virus
Ebola virus is a highly pathogenic RNA virus that causes haemorrhagic fever in human. With very high mortality rate, Ebola virus is considered as one of the dangerous viruses in the world.
M. Ullah, Bishajit Sarkar, S. Islam
semanticscholar +1 more source
Care and COVID 19: Lessons for liberals and neoliberals
Abstract Within the liberal political traditions, care is regarded as a private matter, a problem of ethics rather than justice. Social justice is framed as an issue of economics (re/distribution), culture (recognition) and/or politics (representation).
Kathleen Lynch
wiley +1 more source
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
Ebola virus is the causative agent of Ebola virus disease in humans. The lethality of Ebola virus infection is about 50%, supporting the urgent need to develop anti-Ebola drugs.
Qinghua Cui +7 more
doaj +1 more source
Assessment of Environmental Contamination and Environmental Decontamination Practices within an Ebola Holding Unit, Freetown, Sierra Leone. [PDF]
Evidence to inform decontamination practices at Ebola holding units (EHUs) and treatment centres is lacking. We conducted an audit of decontamination procedures inside Connaught Hospital EHU in Freetown, Sierra Leone, by assessing environmental swab ...
Daniel Youkee +10 more
doaj +1 more source

